Biosimilars Surveillance Program Gears Up For Infliximab And Insulin
This article was originally published in The Pink Sheet Daily
Executive Summary
With preliminarily Zarxio data expected shortly, consortium of payers and sponsors is laying groundwork to monitor future biosimilar launches.